It was reported that loss of maspin expression during tumor progression resulted from both the absence of transactivation through the Ets element and the presence of transcription repression through the negative hormonal responsive element (HRE) recognized by androgen receptor [21]. The gene discussed is AR; the disease is neoplasm.